Table 2.
Reference | Case | Age at diagnosis | Family history | Perinatal edema | Splenectomy (age) | Thrombotic events | Stomatocytes | Typical HX ektacytometry | Hb (g/dL) | MCV (fL) | MCHC (%) | Retics (109/L) | Ferritin (ng/mL) | HFE |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
[11] | K1 | 16 | No | No | n.a. | n.a. | n.a. | Yes | 10.3 | 102.8 | 32.5 | 136 | n.a. | n.a. |
[11] | K2 | 15 | n.a. | n.a. | n.a. | n.a. | n.a. | Yes | 14.4 | 98.5 | 36 | 202 | n.a. | n.a. |
[11] | K3 | 11 | Yes | n.a. | n.a. | n.a. | n.a. | Yes | 11.3 | 91.9 | 37.3 | 275 | n.a. | n.a. |
[11] | K5 | 21 | Yes | No | n.a. | n.a. | n.a. | Yes | 12.7 | 98.9 | 37.5 | 256 | n.a. | n.a. |
[11] | K6 | 18 | Yes | No | n.a. | n.a. | n.a. | Yes | 12.5 | 102.5 | 36 | 378 | n.a. | n.a. |
[11] | K7 | 42 | Yes | n.a. | n.a. | n.a. | n.a. | Yes | 12.6 | 108.6 | 36.5 | 290 | n.a. | n.a. |
[11] | F2 | 30 | Yes | Yes | No | — | n.a. | Yes | 9.4 | 99.1 | n.a. | 182 | n.a. | n.a. |
[11] | F3 | 26 | Yes | No | Yes (27) | Yes | 5% | Yes | 13.9 | 120 | 33.8 | 220 | 2910 | n.a. |
[17] | Daughter # | 50 | Yes | No | Yes (38) | No | Yes | n.a. | 7.9 | 133.9 | n.a. | 3.9% | 4315 | wt |
[17] | Son # | 41 | Yes | No | No | — | Yes | n.a. | 6.6 | 101.1 | n.a. | 4.9% | 4350 | wt |
This study | AII.1$ | 55 | Yes | No | Yes (21) | Yes | 13% | Yes | 11 | 108 | 36.5 | 166 | 939 | H63D/wt |
This study | AII.2$ | 50 | Yes | No | No | — | 15% | Yes | 13 | 103 | 37.8 | 273 | 1571 | H63D/wt |
This study | BII.1 | 23 | Yes | No | Yes (23) | No | 33% | Yes | 12 | 100 | 38 | 198 | 356 | wt |
This study | BIII.1∗ | Birth | Yes | No | No | — | 22% | Yes | 10.8 | 66.4 | 36.2 | 423 | 321 | n.a. |
∗HX associated with β-thalassemia trait; $HX associated with heterozygote PK deficiency.
#HX associated with hereditary high phosphatidylcholine haemolytic anaemia (HHPCHA).
n.a. = not available.